Review
Flow diverter stents in the treatment of intracranial aneurysms: Where are we?Flow diverters dans le traitement des anévrismes intracrâniens : où en sommes-nous ?

https://doi.org/10.1016/j.neurad.2010.12.002Get rights and content

Summary

Flow diverter stents are devices designed to treat complex aneurysms. According to preliminary series published in the literature, treatment of aneurysms with flow diverters is highly efficacious with acceptable morbidity and mortality. Delayed aneurysm ruptures have been reported but mechanisms are actually not completely elucidated. In-stent thrombosis or stenosis was also observed. Indications of flow diverters are complex aneurysms (fusiform, large and giant, wide neck, small aneurysms untreatable by conventional coiling) as well as recurrences. Several randomized studies and registries are actually in progress and will contribute to a more precise knowledge of the place of the flow diverters in the treatment of intracranial aneurysms.

Section snippets

Conceptual basis

The goal is primarily to reconstruct the diseased vascular segment harboring the saccular or fusiform aneurysm pouch. The device used for parent vessel reconstruction produces hemodynamic and biological effects:

  • flow redirection: the flow diverter crosses the aneurysm neck and diverts the blood flow from the aneurysm sac, thus reducing shear stress on the aneurysm wall and promoting intra-aneurysm flow stasis and thrombosis. This phenomenon is affected by the amount of metal surface area

Devices

Two devices are currently included in the flow diverter group:

  • Pipeline embolization device ([PED], EV3-MTI, Irvine, CA) is a self-expanding, flexible, cylindrical mesh-like device, composed of 25% platinum tungsten and 75% cobalt chromium, made from 48 strands interwoven in a standard pattern (Figure 1, Figure 2). The PED has a diameter between 2.5 and 5 mm and a length between 10 and 35 mm;

  • Silk (Balt, Montmorency, France) is a self-expanding stent made of 48 braided nitinol strands (Figure 1,

Feasibility of aneurysm treatment with flow diverters

Preliminary clinical experience with flow diverters for treating intracranial aneurysms was reported in case reports and patient series [9], [10], [11], [12], [13], [14], [15], [16]. Our analysis is focused on the series reporting mono- or multicenter results with PED or Silk [9], [10], [11], [12]. In Lylyk et al. [9] monocenter series of 53 patients with 63 aneurysms, no failure was reported using the PED. Treatment was achieved with a single PED in 44 aneurysms but with two or three PEDs in

Safety of flow diverters

No major complications were reported in the series of Lylyk et al. [9] Three patients (5%) experienced transient exacerbations of preexisting cranial neuropathies and headache. Giant aneurysms were treated in all cases and symptoms resolved within 1 month using corticosteroids treatment. Szikora et al. [10] observed clinical complications in four cases:

  • mild hemiparesis for 2 days due to contrast overload;

  • small visual field defect due to occlusion of a retinal artery branch;

  • transient hemiparesis

Efficacy of flow diverters

According to the current series published in the literature, the treatment of intracranial aneurysms with flow diverters is associated with a high rate of complete aneurysm occlusion.

Since endovascular treatment using flow diverters is not performed by filling the aneurysm with devices but by covering the neck, the Montreal scale is probably not completely appropriate to evaluate anatomic results. A new grading schema has recently been designed to audit outcomes of patients treated with flow

Perioperative medications

Perioperative medications are quite important in the management of intracranial aneurysms with flow diverters since there are competing risks of thromboembolic complications, including in-stent thrombosis and delayed aneurysm rupture (see below).

In all series, patients were treated with heparin during the procedure, heparin anticoagulation being discontinued at the end of the procedure.

The antiplatelet regimen was heterogeneous from one series to another. Several types of pre-medication were

Delayed aneurysm rupture after flow diversion treatment

Several papers have recently documented the occurrence of delayed aneurysm rupture after flow diversion treatment [19], [20], [21] (Fig. 4). Kulcsar et al. [20] reported 13 delayed ruptures after Silk treatment. Patients were separated into two groups with early (< 3 months) and late (≥ 3 months) ruptures. Early rupture was more frequent (10/13 patients) and occurred 2 to 48 days after the treatment (mean time to rupture: 16 days), and was encountered in patients still receiving aspirin and

Present indications of flow diverters

The precise indications of flow diversion are not yet precisely established. In the series published in the literature, flow diverters were mainly used in the series already published in the literature in large and giant aneurysms, wide neck aneurysms, and recurrent aneurysms. A small series has suggested the value of flow diversion treatment in very small aneurysms untreatable by standard coiling technique [23].

Studies in progress

Several studies, including randomized trials, are currently underway. They will provide more precise information regarding safety and efficacy of flow diversion for treating intracranial aneurysms with respect to standard endovascular techniques (balloon-assisted or stent-assisted coiling). Well-conducted clinical investigations will also provide information concerning the treatment indication for difficult-to-treat complex aneurysms, as well as noncomplex aneurysms.

Conclusion

The treatment of intracranial aneurysms with flow diverters seems to be highly efficacious. According to preliminary series, safety of this treatment seems to be satisfactory, specifically in the context of treating complex aneurysms with these devices. However, the frequency and the mechanism of delayed rupture after flow diversion must be analyzed in order to precisely define the indications of this technique, the appropriate perioperative medications, and the way the treatment is performed

Conflicts of interest statement

Laurent Pierot is consultant for Balt, Boston Scientific, EV3 and Microvention.

References (23)

  • B. Lubicz et al.

    Solitaire stent for endovascular treatment of intracranial aneurysms: immediate and mid-term results in 15 patients with 17 aneurysms

    J Neuroradiol

    (2010)
  • A.J. Molyneux et al.

    International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial

    Lancet

    (2002)
  • L. Pierot et al.

    Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study

    Stroke

    (2008)
  • L. Pierot et al.

    Endovascular treatment of unruptured intracranial aneurysms: comparison of safety of remodelling technique and standard treatment with coils

    Radiology

    (2009)
  • Pierot L, Cognard C, Anxionnat R, Ricolfi F, for the CLARITY group. The remodelling technique for endovascular...
  • M. Piotin et al.

    Stent-assisted coiling of intracranial aneurysm. Clinical and angiographic results in 216 consecutive aneurysms

    Stroke

    (2010)
  • C. Sadavisan et al.

    An original flow diversion device for the treatment of intracranial aneurysms: evaluation in the rabbit elastase-induced model

    Stroke

    (2009)
  • D.F. Kallmes et al.

    A new endoluminal, flow-disrupting device for treatment of saccular aneurysms

    Stroke

    (2007)
  • P. Lylyk et al.

    Curative Endovascular Reconstruction of cerebral Aneurysms with the Pipeline Embolization Device: the Buenos Aires Experience

    Neurosurgery

    (2009)
  • I. Szikora et al.

    Treatment of Intracranial Aneurysms by Functional Reconstruction of the Parent Artery: the Budapest Experience with the Pipeline Embolization Device

    AJNR Am J Neuroradiol

    (2010)
  • J.V. Byrne et al.

    Early Experience in the Treament of Intracranial Aneurysms by Endovascular Flow Diversion: a Multicentre Prospective Study

    PloS One

    (2010)
  • Cited by (115)

    • Simulation of intra-saccular devices for pre-operative device size selection: Method and validation for sizing and porosity simulation

      2022, Computers in Biology and Medicine
      Citation Excerpt :

      The endovascular treatment of intracranial aneurysms has become the preferred choice when treating this pathology. Aneurysms placed in bifurcations are particularly challenging to treat with “standard” devices (coils, stents or FD) because of the necessity to preserve both arteries [5]. A special alternative stent treatment is used in some cases, however, sometimes the branches opposite to the stent were occluded [6].

    • Flow diverter embolization device for endovascular treatment of ruptured blister and wide necked very small aneurysms

      2019, Heliyon
      Citation Excerpt :

      Also, we had a positive experience with FDDs for treatment of traumatic and iatrogenic internal carotid artery injuries showing that flow diversion is effective in healing vessel wall damages [22]. Although flow diverter implantation creates an immediate hemodynamic effect in the parent artery and aneurysmal sac, progressive thrombosis and complete occlusion of the aneurysm only occurs within weeks after the procedure [23]. During this ‘latency period’, there is a risk of re-rupture or re-bleeding [14].

    View all citing articles on Scopus
    View full text